Cargando…

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”

Detalles Bibliográficos
Autores principales:	Huang, Lu, Yang, Qiong, Chen, Huihong, Wang, Zhenggeng, Liu, Qi, Ai, Shuhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2022
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191560/ https://www.ncbi.nlm.nih.gov/pubmed/35799604 http://dx.doi.org/10.1515/med-2022-0501

Ejemplares similares

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022)

Erratum to HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation
Publicado: (2022)

PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum
por: Du, Peng, et al.
Publicado: (2022)

Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways: Erratum
por: Zhang, Jinjun, et al.
Publicado: (2023)

Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum
por: Wu, Deng-Pan, et al.
Publicado: (2022)

Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer?
por: Garrett, Joan T., et al.
Publicado: (2018)

Erratum in: S100A4 Silencing Facilitates Corneal Wound Healing After Alkali Burns by Promoting Autophagy via Blocking the PI3K/Akt/mTOR Signaling Pathway
Publicado: (2021)

Activation of the PI3K/Akt/mTOR/p70S6K Pathway is Involved in S100A4-Induced Viability and Migration in Colorectal Cancer Cells: Erratum
por: Wang, Haiyan, et al.
Publicado: (2022)

Erratum for: miR-26a-5p protects against myocardial ischemia/reperfusion injury by regulating the PTEN/PI3K/AKT signaling pathway
Publicado: (2020)

Erratum: 17β-Estradiol Inhibites Tumor Necrosis Factor-α Induced Apoptosis of Human Nucleus Pulposus Cells via the PI3K/Akt Pathway
por: Wang, Tao, et al.
Publicado: (2021)

Tollip or Not Tollip: What Are the Evolving Questions behind It?
por: Luiz, Denis Prudencio, et al.
Publicado: (2014)

Erratum to: Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells
por: Befani, C. D., et al.
Publicado: (2013)

CHL1 suppresses tumor growth and metastasis in nasopharyngeal carcinoma by repressing PI3K/AKT signaling pathway via interaction with Integrin β1 and Merlin: Erratum
por: Chen, Juan, et al.
Publicado: (2023)

Erratum: Vitexin Inhibits Gastric Cancer Growth and Metastasis through HMGB1-mediated Inactivation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway
por: Zhou, Peng, et al.
Publicado: (2022)

Erratum: Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation
por: Toricelli, Mariana, et al.
Publicado: (2015)

ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
por: Ni, Sheng, et al.
Publicado: (2020)

Erratum to miR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer
Publicado: (2022)

Erratum to “Epithelial Cells Attenuate Toll-Like Receptor-Mediated Inflammatory Responses in Monocyte-Derived Macrophage-Like Cells to Mycobacterium tuberculosis by Modulating the PI3K/Akt/mTOR Signaling Pathway”
por: Yang, Yi, et al.
Publicado: (2021)

PI3K/Akt/HIF-1α signaling pathway mediates HPV-16 oncoprotein-induced expression of EMT-related transcription factors in non-small cell lung cancer cells: Erratum
por: Liu, Jinhua, et al.
Publicado: (2023)

TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
por: Ye, Yanqing, et al.
Publicado: (2023)

Erratum: Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways
por: Kral, Julia Barbara, et al.
Publicado: (2016)

Cytochalasin H Inhibits Angiogenesis via the Suppression of HIF-1α Protein Accumulation and VEGF Expression through PI3K/AKT/P70S6K and ERK1/2 Signaling Pathways in Non-Small Cell Lung Cancer Cells: Erratum
por: Ma, Yuefan, et al.
Publicado: (2023)

Erratum: Majewska, E. et al. Transfection with GLS2 Glutaminase (GAB) Sensitizes Human Glioblastoma Cell Lines to Oxidative Stress by a Common Mechanism Involving Suppression of the PI3K/AKT Pathway. Cancers 2019, 11, 115
por: Majewska, Ewelina, et al.
Publicado: (2020)

Erratum to “Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt Signaling Pathways”
por: Chen, Ying-Yi, et al.
Publicado: (2013)

IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways
por: Duan, Shiyu, et al.
Publicado: (2018)

Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma: Erratum
por: Liu, Zhikui, et al.
Publicado: (2023)

NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling
por: Gong, Chengwu, et al.
Publicado: (2019)

CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways: Erratum
por: Han, Jing, et al.
Publicado: (2023)

Erratum: CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities
por: Terry, Stéphane, et al.
Publicado: (2019)

ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway
por: Cui, Yong, et al.
Publicado: (2022)

MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
por: Zhang, Zhenyu, et al.
Publicado: (2018)

Retraction: MicroRNA-367 promotes progression of hepatocellular carcinoma through PTEN/PI3K/AKT signaling pathway
Publicado: (2020)

Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway
por: Han, Wei, et al.
Publicado: (2022)

VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
por: Pu, Zhangya, et al.
Publicado: (2022)

Up-Regulation of RACGAP1 Promotes Progressions of Hepatocellular Carcinoma Regulated by GABPA via PI3K/AKT Pathway
por: Gu, Yang, et al.
Publicado: (2022)

Overexpression of YEATS2 Remodels the Extracellular Matrix to Promote Hepatocellular Carcinoma Progression via the PI3K/AKT Pathway
por: Liu, Xin, et al.
Publicado: (2023)

Moxidectin induces Cytostatic Autophagic Cell Death of Glioma Cells through inhibiting the AKT/mTOR Signalling Pathway: Erratum
por: Liu, Jingjing, et al.
Publicado: (2023)

Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023)

Erratum for Juvenile Hepatocellular Carcinoma in a Healthy Liver
por: Onishi, Sachiyo, et al.
Publicado: (2022)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vq596nesg4ck064c60oneqslha